BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
173 results:

  • 1. [Study of genetic variants in 169 non-small cell lung cancer patients].
    Formanti Alonso L; Atienza Cuevas L; Romero García R; Mohigefer Barrera J; Del Río Ignacio JJ; Santisteban Espejo A; Bernal Florindo I; Catalina Fernández I; García Rojo M
    Rev Esp Patol; 2023; 56(4):233-242. PubMed ID: 37879820
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant lung cancer.
    Stockhammer P; Grant M; Wurtz A; Foggetti G; Expósito F; Gu J; Zhao H; Choi J; Chung S; Li F; Walther Z; Dietz J; Duffield E; Gettinger S; Politi K; Goldberg SB
    J Thorac Oncol; 2024 Feb; 19(2):240-251. PubMed ID: 37806385
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Giraud JS; Bièche I; Pasmant É; Tlemsani C
    Expert Opin Investig Drugs; 2023; 32(10):941-957. PubMed ID: 37747491
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma.
    Yousefi M; Andrejka L; Szamecz M; Winslow MM; Petrov DA; Boross G
    Proc Natl Acad Sci U S A; 2023 Sep; 120(38):e2303224120. PubMed ID: 37695905
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma.
    Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW
    JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. mRNA markers associated with malignant pleural effusion.
    Hsu SC; Chang SY; Hwang YT; Terng HJ; Tsai CL; Shen CH; Huang SK; Chian CF
    Sci Rep; 2023 Apr; 13(1):6677. PubMed ID: 37095178
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trametinib in Patients With
    Wisinski KB; Flamand Y; Wilson MA; Luke JJ; Tawbi HA; Hong F; Mitchell EP; Zwiebel JA; Chen H; Gray RJ; Li S; McShane LM; Rubinstein LV; Patton D; Williams PM; Hamilton SR; Behrens RJ; Pennington KP; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
    JCO Precis Oncol; 2023 Apr; 7():e2200421. PubMed ID: 37053535
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological features and genomic analysis of bronchiolar adenoma.
    Bo J; Chen X; Zhang T; Zhu X; Zhang L; Liu Y; Zhang H; Wu C; Mou S; Yi X; Rui W; Zeng Y
    Histol Histopathol; 2023 Dec; 38(12):1465-1474. PubMed ID: 36988010
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mapping Multi-factor-mediated Chromatin Interactions to Assess Dysregulation of lung cancer-related Genes.
    Zhang Y; Zhang J; Zhang W; Wang M; Wang S; Xu Y; Zhao L; Li X; Li G
    Genomics Proteomics Bioinformatics; 2023 Jun; 21(3):573-588. PubMed ID: 36702236
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
    Grenda A; Krawczyk P; Targowska-Duda KM; Kieszko R; Paśnik I; Milanowski J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674722
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
    Shi DM; Dong SS; Zhou HX; Song DQ; Wan JL; Wu WZ
    Cell Signal; 2023 Apr; 104():110565. PubMed ID: 36539000
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.
    Chen S; Guan L; Zhao X; Yang J; Chen L; Guo M; Zhao J; Chen C; Zhou Y; Han Y; Xu L
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):915-930. PubMed ID: 36379611
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples.
    Husain H; Pavlick DC; Fendler BJ; Madison RW; Decker B; Gjoerup O; Parachoniak CA; McLaughlin-Drubin M; Erlich RL; Schrock AB; Frampton GM; Das Thakur M; Oxnard GR; Tukachinsky H
    JCO Precis Oncol; 2022 Oct; 6():e2200261. PubMed ID: 36265119
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bioinformatic Analysis Identifies of Potential miRNA-mRNA Regulatory Networks Involved in the Pathogenesis of lung cancer.
    Hao D; Li Y; Shi J; Jiang J
    Comput Intell Neurosci; 2022; 2022():6295934. PubMed ID: 36211008
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
    Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
    J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
    Wen Q; Ge J; Lei Y; Zhang Y; Kong X; Wang W; Hou H; Wang Z; Qian S; Ding M; Dong M; Zhu L; Zhang M; Zhang X; Chen Q
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3989-4003. PubMed ID: 36030432
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.
    Liu C; Liu C; Liao J; Yin JC; Wu X; Zhao X; Sun S; Wang H; Hu Z; Zhang Y; Yu H; Shao Y; Wang J
    Lung Cancer; 2022 Sep; 171():18-25. PubMed ID: 35870258
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
    Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
    JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.